SI-BONE Inc. (SIBN) Misses Q3 EPS by 2c, Slight Beat on Revenues; Offers FY18 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
SI-BONE, Inc. Reports Third Quarter 2018 Financial Results
November 29, 2018 4:12 PM ESTSANTA CLARA, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System, today reported financial results for the quarter ended September 30, 2018.
Recent Highlights
Revenues of $13.4 million for the third quarter of 2018, representing a 15% increase over third quarter 2017Exclusive payer coverage policies from Blue Cross Blue Shield North Carolina and Neighborhood Health Plan and a positive coverage policy from HealthPartnersExclusive coverage policy recommendation from EviCore, a specialty benefits company,... More